Cefprozil and Doxycycline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefprozil (cefprozil) and Doxycycline (doxycycline hyclate). Common drug interactions include haemoptysis among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Cefprozil and Doxycycline. It is created by eHealthMe based on reports of 82 people who take the same drugs from the FDA, and is updated regularly.

What is Cefprozil?

Cefprozil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,103 Cefprozil users. Check the latest studies of Cefprozil.

What is Doxycycline?

Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 60,866 Doxycycline users. Check the latest studies of Doxycycline.

On Jul, 17, 2026

82 people who take Cefprozil and Doxycycline together, and have interactions are studied.

Cefprozil and Doxycycline drug interactions.

What are the common drug interactions of Cefprozil and Doxycycline, by gender? *:

female:

Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Hypotension (abnormally low blood pressure)
Infusion site scar
Muscular weakness (muscle weakness)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Pruritus (severe itching of the skin)
Sepsis (a severe blood infection that can lead to organ failure and death)
Weight decreased
Infusion site reaction

male:

Fatigue (feeling of tiredness)
Cough
White blood cell count decreased
Chronic kidney disease
Dizziness
Mood swings (an extreme or rapid change in mood)
Nasopharyngitis (inflammation of the nasopharynx)
Renal failure (kidney dysfunction)
Tooth disorder (tooth disease)
Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Cefprozil and Doxycycline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Pneumonia
Vomiting

30-39:

Anaemia (lack of blood)
Asthma
Blood alkaline phosphatase increased
Blood bilirubin increased
Blood lactate dehydrogenase increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic obstructive airways disease
Gamma-glutamyltransferase increased
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Pneumonia

40-49:

Heart rate increased
Influenza
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Oropharyngeal pain
Memory impairment
White blood cell count decreased
Pain
Chronic kidney disease
Mood swings (an extreme or rapid change in mood)

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Nephrogenic anaemia (anaemia due to kidney disease)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Renal injury (kidney injury)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Drug hypersensitivity

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Gingivitis (inflammation of gums)
Headache (pain in head)
Infusion site discomfort
Infusion site erythema (reddening of the skin at infusion site)
Infusion site haemorrhage (bleeding from infusion site)
Infusion site pain
Localised infection (infection at the single location)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 21 people, 25.61%
Immunodeficiency Common Variable: 20 people, 24.39%
Pain: 18 people, 21.95%
Infection: 16 people, 19.51%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 15 people, 18.29%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 15 people, 18.29%
High Blood Pressure: 14 people, 17.07%
High Blood Cholesterol: 14 people, 17.07%
Stress And Anxiety: 9 people, 10.98%
Cardiac Disorder: 8 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cefprozil and Doxycycline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously